Citi Upgrades Editas Medicine (EDIT) to Buy, Opens 30-Day Upside Catalyst Watch
Tweet Send to a Friend
(Updated - October 24, 2023 5:05 AM EDT)
Citi analyst Samantha Semenkow upgraded Editas Medicine (NASDAQ: EDIT) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Samantha Semenkow upgraded Editas Medicine (NASDAQ: EDIT) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
